Effect of Semaglutide in Patients with the Clinically Significant Weight Regain (WR) There were no significant differences in age, sex, or baseline comorbidities between WR and non-WR groups
22, 169173 [DOI] [PubMed] [Google Scholar] Matsusue A., Hara K., Kashiwagi M., Kageura M., Sugimura T., Kubo S
That makes it unclear whether the association reflected alpha-ketoglutarate itself, the delayed-release formulation, the added vitamins, or other differences among users
We try our best to ensure that you have a 100 satisfactory shopping experience
In one study where glutamine was used along with chemoradiotherapy for non-small cell lung cancer, the nutrient did not interfere with treatment efficacy and helped prevent weight loss and unplanned treatment delays (Topkan 2012)